Advertisement

16 How Recreational Drugs Affect Asthma

  • Timothy E. Albertson
  • Steve Offerman
  • Nicholas J. Kenyon
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

  • Because of the recent epidemic, drugs of abuse have more opportunity to interact with a common disease such as asthma.

  • Drugs of abuse have not been proven to cause asthma, but they may exacerbate preexisting asthma.

  • Case reports of asthma exacerbations after recreational drug abuse continue to increase.

  • Abuse of cocaine and the opioid heroin have the richest literature supporting an interaction with asthma and offer possible pathophysiological mechanisms.

  • Marijuana use, like tobacco use, can lead to a progressive decline in lung function.

  • Tobacco use, but not nicotine addiction, is associated with worsening of asthma and obstructive pulmonary function changes.

  • Healthcare providers need to specifically question their patients with asthma about recreational drug use and educate them about potential interactions.

  • The only definitive treatment to eliminate any potential interaction between drug abuse and asthma is abstinence.

Keywords

Environmental Tobacco Smoke Recreational Drug Tracheal Stenosis Cocaine Abuse Eosinophilic Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carlisle MJ. Update: comparison of drug use in Australia and the United States in the 2001 National Household Surveys. Drug Alcohol Rev 2003; 22: 347–357.CrossRefGoogle Scholar
  2. 2.
    Albertson TE, Gershwin ME, Eds. Pulmonary complications of recreational drug usage. Clin Rev in Allergy Immunol 1997; 15: 219–361.Google Scholar
  3. 3.
    Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med 2001; 7: 43–61.PubMedCrossRefGoogle Scholar
  4. 4.
    Barsky SH, Roth MD, Kleerup EC, et al. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco.JNatl Cancer Inst 1998; 90: 1198–1205.CrossRefGoogle Scholar
  5. 5.
    Waldbott GL. Asthma due to a local anesthetic. JAMA 1932; 99: 1942–1945.Google Scholar
  6. 6.
    Weiss KB, Gergen PG, Crain EF. The epidemiology of an emerging US public health concern. Chest 1992; 101: 362S–367S.PubMedCrossRefGoogle Scholar
  7. 7.
    Greenberger PA, Miller TP, Lifschultz B. Circumstances surrounding deaths from asthma in Cook County, Illinois. Allg Proc 1993; 14: 321–326.CrossRefGoogle Scholar
  8. 8.
    Levenson T, Greenberger PA, Donoghue ER, et al. Asthma deaths confounded by substance abuse. An assessment of asthma. Chest 1996; 110: 664–710.CrossRefGoogle Scholar
  9. 9.
    Osborn HH, Tang M, Bradley K, et al. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med 1991: 20: 211–212.Google Scholar
  10. 10.
    Panacek EA, Jouriles NJ, Singer A, et al. Is unexplained bronchospasm associated with the use of cocaine? Ann Emerg Med 1991; 20: 211–212.Google Scholar
  11. 11.
    Rome LA, Lippmann ML, Dalsey WC, et al. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000; 117: 1324–1329.PubMedCrossRefGoogle Scholar
  12. 12.
    Rubin RB, Neugarten J. Cocaine-associated asthma. Am J Med 1990; 88: 438–439.PubMedCrossRefGoogle Scholar
  13. 13.
    Rebhun J. Association of asthma and freebase smoking. Ann Allergy 1988; 60: 339–342.PubMedGoogle Scholar
  14. 14.
    Rao AN, Polos PG, Walther FA. Crack abuse and asthma: a fatal combination. NYS J Med 1990; 90: 511–512.Google Scholar
  15. 15.
    Averbach M, Casey KK, Frank E. Near-fatal status asthmaticus induced by nasal insufflation of cocaine. So Med J 1996; 89: 340–341.CrossRefGoogle Scholar
  16. 16.
    Meisels IS, Loke J. The pulmonary effects of free-base cocaine: a review. Clev Clin J Med 1993; 60: 325–329.Google Scholar
  17. 17.
    Dean NC, Clark HW, Doherty JJ, et al. Pulmonary function in heavy users of &quote;freebase&quote; cocaine. Am RevRespirDis 1988; 137S: 489.Google Scholar
  18. 18.
    Weiss RD, Goldenheim PD, Mirin SM, et al. Pulmonary dysfunction in cocaine smokers. Am J Psychiatry 1981; 138: 1110–1112.PubMedGoogle Scholar
  19. 19.
    Weiss RD, Tilles DS, Goldenheim PD, et al. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Depend 1987; 19: 271–276.PubMedCrossRefGoogle Scholar
  20. 20.
    Susskind H, Weber DA, Vokow ND, et al. Increased lung permeability following long-term use of free-base cocaine. Chest 1991; 100: 903–909.PubMedCrossRefGoogle Scholar
  21. 21.
    Itkonen J, Schnoll S, Glassroth J, et al. Pulmonary dysfunction in &quote;freebase&quote; cocaine users. Arch Intern Med 1984; 144: 2195–2197.PubMedCrossRefGoogle Scholar
  22. 22.
    Tashkin DP, Kleerup EC, Koyal SN, et al. Acute effects of inhaled and IV cocaine on airway dynamics. Chest 1996; 110: 904–910.PubMedCrossRefGoogle Scholar
  23. 23.
    Kissner DG, Lawrence WD, Selis JE, et al. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1987; 136: 1250–1252.PubMedGoogle Scholar
  24. 24.
    Kikuchi Y, Okabe S, Tamura G, et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 1994: 330: 1329–1334.PubMedCrossRefGoogle Scholar
  25. 25.
    Zaas D, Brock M, Yang S, et al. An uncommon mimic of an acute asthma exacerbation. Chest 2002; 121: 1707–1709.PubMedCrossRefGoogle Scholar
  26. 26.
    Dowling GP, McDonough ET, Bost RO. ’Eve’ and’ Ecstasy’. A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987: 257: 1615–1617.PubMedCrossRefGoogle Scholar
  27. 27.
    Saito T, Yamanamoto I, Kusakabe T, et al. Determination of chronic methamphetamine abuse by hair analysis. Forensic Sci Int 2000; 112: 65–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmidt RA, Glenny RW, Godwin JD, et al. Panlobular emphysema in young intravenous Ritalin abusers. Am Rev Respir Dis 1991; 143: 649–656.PubMedGoogle Scholar
  29. 29.
    Sherman CB, Hudson LD, Pierson DJ. Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 1987; 92: 1085–1087.PubMedCrossRefGoogle Scholar
  30. 30.
    Del los Santos-Sartre S, Capote-Gil F, Gonzales-Castro A. Airway obstruction and heroin inhalation. Lancet 1986; 2: 1158.CrossRefGoogle Scholar
  31. 31.
    Oliver RM. Bronchospasm and heroin inhalation. Lancet 1986; 1: 915.PubMedCrossRefGoogle Scholar
  32. 32.
    Anderson K. Bronchospasm and intravenous street heroin. Lancet 1986; 1: 1208.PubMedCrossRefGoogle Scholar
  33. 33.
    Hughes S, Calverley PMA. Heroin inhalation and asthma. Br Med J 1988; 297: 1611–1612.Google Scholar
  34. 34.
    Sapira JD. The narcotic addict as a medical patient. Am J Med 1968; 45: 555–587.PubMedCrossRefGoogle Scholar
  35. 35.
    Ghodse AH, Wilson AF, Berke RA. Asthma in opiate addicts. J Psychosom Res 1987; 31: 41–44.PubMedCrossRefGoogle Scholar
  36. 36.
    Cruz R, Davis M, O’Neill H, et al. Pulmonary manifestations of inhaled street drugs. Heart Lung 1998; 27: 297–305.PubMedCrossRefGoogle Scholar
  37. 37.
    Brander PE, Tukianinen P. Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J 1993; 6: 750–752.PubMedGoogle Scholar
  38. 38.
    Spiritus EM, Wilson AF, Berke RA. Lung scans in asymptomatic heroin addicts. Am Rev Respir Dis 1973; 108: 994–996.PubMedGoogle Scholar
  39. 39.
    Camargo G, Colp C. Pulmonary function studies in ex-heroin users. Chest 1975; 67: 331–334.PubMedCrossRefGoogle Scholar
  40. 40.
    Overland ES, Nolan AJ, Hopewell PC. Alteration of pulmonary function in intravenous abusers. Am JMed 1980; 68: 231–237.Google Scholar
  41. 41.
    Krantz AJ, Hershow RC, Prachand N, et al. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003; 123: 510–517.PubMedCrossRefGoogle Scholar
  42. 42.
    Eschenbacher WL, Bethel RA, Boushey HA, et al. Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose responses are inhibited by atropine. Am Rev Respir Dis 1984: 130: 363–367.PubMedGoogle Scholar
  43. 43.
    Mestiri M, Lurie A, Frossard N, et al. Effect of inhaled morphine on the bronchial responsiveness to isocapnic hyperventilation in patients with allergic asthma. Eur J Clin Pharm 1991; 41: 621.CrossRefGoogle Scholar
  44. 44.
    Field PL, Simmul R, Bell SC, et al. Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide-induced bronchoconstriction. Thorax 1996; 51: 159–163.PubMedGoogle Scholar
  45. 45.
    Ulinski S, Palczynski C, Gorski P. Occupational rhinitis and bronchial asthma due to morphine: evidence from inhalational and nasal challenges. Allergy 1996; 51: 914–918.PubMedGoogle Scholar
  46. 46.
    Biagnini RE, Klincewicz SL, Henningsen GM. Antibodies to morphine in workers exposed to opiates at a narcotics’ manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci 1993; 53: 99–105.CrossRefGoogle Scholar
  47. 47.
    Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual, heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and non-smokers. Am Rev Respir Dis 1987; 135: 209–215.PubMedGoogle Scholar
  48. 48.
    Bloom JW, Kaltenborn WT, Paoletti P, et al. Respiratory effects of non-tobacco cigarettes. Br Med J 1987; 295: 1516–1518.Google Scholar
  49. 49.
    Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction 2000; 95: 1669–1677.PubMedCrossRefGoogle Scholar
  50. 50.
    Tashkin DP, Shapiro FJ, Frank IM. Acute effects of smoked marijuana and Delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis 1974; 109: 420–428.PubMedGoogle Scholar
  51. 51.
    Tashkin DP, Simmons MS, Chang P, et al. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am Rev Respir Dis 1993; 147: 125–129.Google Scholar
  52. 52.
    Friedman H, Klein TW, Newton C, et al. Marijuana, receptors and immunomodulation. Adv Exp Med Biol 1995; 373: 103–113.PubMedGoogle Scholar
  53. 53.
    Spector SC, Klein TW, Newton C, et al. Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannibinol. Int J Immunopharmacol 1986; 8: 741–745.CrossRefGoogle Scholar
  54. 54.
    US Center for Disease Control and Prevention. Tobacco use and usual source of cigarettes among high school students-United States, 1995 MMWR Morbid Mortal Wkly Rep 1996; 45: 413–418.Google Scholar
  55. 55.
    US Center for Disease Control and Prevention. Prevalence of cigarette use among 14 racial/ethnic population-United States, 1999-2001. MMWR Morbid Mortal Wkly Rep 2004; 53: 49–52.Google Scholar
  56. 56.
    American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861–865.Google Scholar
  57. 57.
    Willers S, Svenonius E, Skarping G. Passive smoking and childhood asthma. Allergy 1991; 46: 330–334.PubMedCrossRefGoogle Scholar
  58. 58.
    Cunningham J, Dockery DW, Speizer FE. Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol 1994; 139: 1139–1152.PubMedGoogle Scholar
  59. 59.
    Weiss ST.Environmental risk factors in childhood asthma. Clin Exp Allergy 1998; 28: 29–34.Google Scholar
  60. 60.
    Annesi-Maesano I, Oryszczyn MP, Raherison C, et al. Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin Exp Allergy 2004; 34: 1017–1023.PubMedCrossRefGoogle Scholar
  61. 61.
    Jang A-S, Choi I-S, Lee S, et al. The effect of passive smoking on asthma symptoms, atopy, and airway hyperresponsiveness in schoolchildren. J Korean Med Sci 2004; 19: 214–217.PubMedCrossRefGoogle Scholar
  62. 62.
    Janson C. The effect of passive smoking on respiratory health in children and adults. Int J Turberc Lung Dis 2004; 8: 510–516.Google Scholar
  63. 63.
    LeSon S, Gershwin ME. Risk factor for asthmatic patients requiring intubation. I. Observations in children. J Asthma 1995; 32: 285–294.PubMedCrossRefGoogle Scholar
  64. 64.
    Eisner MD, Yelin EH, Henke J, et al. Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes. Am J Repir Crit Care Med 1998; 158: 170–175.Google Scholar
  65. 65.
    Flodin U, Jonsson P, Ziegler J, et al. An epidemiologic study of bronchial asthma and smoking. Epidemiology 1995; 6: 503–505.PubMedCrossRefGoogle Scholar
  66. 66.
    White JR, Froeb HF. Small-airways dysfunction in nonsmokers chronically exposed to tobacco smoke. N Engl J Med 1980; 302: 720–723.PubMedGoogle Scholar
  67. 67.
    Schwartz J, Timonen KL, Pekkanen J. Respiratory effects of environmental tobacco smoke in a panel study of asthmatic and symptomatic children. Am J Respir Crit Care Med 2000; 161: 802–806.PubMedGoogle Scholar
  68. 68.
    Chadwick O, Anderson R, Bland M, et al. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. Br Med J 1989; 298: 1679–1683.CrossRefGoogle Scholar
  69. 69.
    Wu LT, Pilowsky DJ, Schlenger WE. Inhalant abuse and dependence among adolescents in the United States. JAmAcad Child Adolesc Psych 2004; 43: 1206–1214.CrossRefGoogle Scholar
  70. 70.
    Schickler KN, Lane EE, Seitz K, et al. Solvent abuse associated pulmonary abnormalities. Concepts Alcohol Subst Abuse 1984; 3: 75–81.Google Scholar
  71. 71.
    Meredith TJ, Ruprah M, Liddle A, et al. Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol 1989; 8: 277–286.PubMedGoogle Scholar
  72. 72.
    Cartwright TR, Brown D, Brashear RE. Pulmonary infiltrates following butane’ fire breathing.’ Arch Int Med 1983; 143: 2007–2008.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Timothy E. Albertson
    • 1
  • Steve Offerman
    • 2
  • Nicholas J. Kenyon
    • 2
  1. 1.Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of MedicineUniversity of California at DavisDavis
  2. 2.Department of Emergency Medicine, School of MedicineUniversity of California at DavisSacramento

Personalised recommendations